|4Sep 17, 9:00 PM ET

Fairmount Healthcare Fund II L.P. 4

4 · Viridian Therapeutics, Inc.\DE · Filed Sep 17, 2024

Insider Transaction Report

Form 4
Period: 2024-09-13
Transactions
  • Purchase

    Common Stock

    2024-09-13$18.75/sh+1,600,000$30,000,0003,445,813 total(indirect: Fairmount Healthcare Fund II LP)
Footnotes (1)
  • [F1]Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the securities held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.

Documents

1 file
  • 4
    tm2424272-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT